CAMBRIDGE, Mass.--(BUSINESS WIRE)--NextPoint Therapeutics, a clinical-stage biotechnology company developing a new class of precision immuno-oncology and tumor-directed therapeutics targeting the ...

Cytolight Red A549 target cells were seeded at 5K cells/well into a 96-well plate in 4Cell ® Nutri-T GMP medium topped up with FBS. Cells were permitted to adhere for 3 hours in a 37 °C, 5 % CO ...

In this webinar, we demonstrate a use case for characterizing the health of starting donor material in cell therapy manufacturing using the Invitrogen™ Attune™ CytPix™ Flow Cytometer to monitor T-cell ...

Discover how cutting-edge tools and analytics are advancing cell therapy, improving precision, safety and scalability in ...

Candid joins a number of high-profile companies that are making waves in the space. In January 2024, MSD acquired Harpoon in a $680m deal, which included Harpoon’s T cell engagers. One of the ...

In a recent article, researchers explored how calcium carbonate nanoparticles enhance T cell activation through calcium signaling, offering new potential for improving cancer immunotherapy outcomes.

Cells were expanded, tested, and cryopreserved. Flow cytometry was used to assess the immune characteristics of the CAR T cells and to check their persistence and function after infusion.

Previously, Pereira et al described successful analysis of the miRNA content of red blood cell derived EVs (RBCEVs) using MBs and nano-flow cytometry. Therefore, in order to validate the plausibility ...

Scientists from the Keck School of Medicine at University of Southern California have developed a spectral flow cytometry-based panel for profiling CAR T cells that could be used to optimize their ...